Brigham and Women's Hospital Pain Management Center
Chestnut Hill, Massachusetts, 02467, United States
NCT Number: NCT04328701
This study seeks to examine multiple risk factors as predictors of pain and function following total knee arthroplasty (TKA). Risk factors will be measured pre-surgically using psychophysical testing procedures, multimodal evaluation of sleep, standardized questionnaires. Additionally, this study will collect pilot data on a brief mindfulness-based cognitive-behavioral treatment that may help to improve long-term TKA outcomes.
The pilot study compared TKA patients that received brief mindfulness-based cognitive behavioral therapy (MBCBT) to the treatment-as-usual (TAU) group from the parent study.
Looking for future studies?
Notify Me45 year–100 year
All sexes
Interventional
Not applicable
Chestnut Hill, Massachusetts, 02467, United States
The present study seeks to collect pilot data on a brief mindfulness-based cognitive-behavioral treatment to determine the feasibility of this intervention and its potential benefits. The study includes 6 total contacts, 1 visit before surgery and 3 after surgery, and 2 phone calls. The last visit will be about 6 months after surgery. The study includes evaluation of peoples' pain, physical functioning, medication use, and physiological responses to sensory stimuli such as heat and cold. The research takes place at the Brigham & Women's Pain Management Center, 850 Boylston St, Chestnut Hill.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mindfulness-based CBT methods are based on pain self-management paradigms, and involve the identification and reduction of maladaptive pain-related cognitions (i.e., catastrophizing), the enhancement of self-efficacy for managing pain, and training in the use of adaptive pain-coping strategies such as relaxation, distraction, and self-talk.
Time frame: baseline
Measure of pain severity and pain interference
Time frame: 6-week
Measure of pain severity and pain interference
Time frame: 3-months
Measure of pain severity and pain interference
Time frame: 6-months
Measure of pain severity and pain interference
Time frame: baseline
Measures of responses to standardized stimuli
Time frame: 3-months
Measures of responses to standardized stimuli
Time frame: baseline
Assess catastrophic thinking related to pain
Time frame: 6-week
Assess catastrophic thinking related to pain
Time frame: 3-months
Assess catastrophic thinking related to pain
Time frame: 6-months
Assess catastrophic thinking related to pain
Time frame: baseline
Measures anxiety and depression symptoms
Time frame: 6-week
Measures anxiety and depression symptoms
Time frame: 3-months
Measures anxiety and depression symptoms
Time frame: 6-months
Measures anxiety and depression symptoms
Time frame: baseline
24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.
Time frame: 6-week
24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.
Time frame: 3-months
24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.
Time frame: 6-months
24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.
Brigham and Women's Hospital
Other
Acronym: POKR-p
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07364578
Arthritis, Joint Diseases
Banī Suwayf, Egypt
View Trial DetailsNCT03895489
Arthritis, Joint Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT06693648
Arthritis, Joint Diseases
Thousand Oaks, California, United States
View Trial DetailsNCT06522906
Arthritis, Behavior
Tucson, Arizona, United States
View Trial Details